Our findings not only corroborate the dysregulation of FTO in ovarian cancer but also build upon existing knowledge by clarifying its association with m6A methylation levels and oncogenic behaviors such as cell proliferation, migration, and invasion.18, 19. The gene discussed is FTO; the disease is ovarian carcinoma.